27257822|t|Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013
27257822|a|We undertook an epidemiological survey of the annual incidence of pertussis reported from 2000 to 2013 in ten Central and Eastern European countries to ascertain whether increased pertussis reports in some countries share common underlying drivers or whether there are specific features in each country. The annual incidence of pertussis in the participating countries was obtained from relevant government institutions and/or national surveillance systems. We reviewed the changes in the pertussis incidence rates in each country to explore differences and/or similarities between countries in relation to pertussis surveillance; case definitions for detection and confirmation of pertussis; incidence and number of cases of pertussis by year, overall and by age group; population by year, overall and by age group; pertussis immunization schedule and coverage, and switch from whole-cell pertussis vaccines (wP) to acellular pertussis vaccines (aP). There was heterogeneity in the reported annual incidence rates and trends observed across countries. Reported pertussis incidence rates varied considerably, ranging from 0.01 to 96 per 100,000 population, with the highest rates generally reported in Estonia and the lowest in Hungary and Serbia. The greatest burden appears for the most part in infants (<1 year) in Bulgaria, Hungary, Latvia, Romania, and Serbia, but not in the other participating countries where the burden may have shifted to older children, though surveillance of adults may be inappropriate. There was no consistent pattern associated with the switch from wP to aP vaccines on reported pertussis incidence rates. The heterogeneity in reported data may be related to a number of factors including surveillance system characteristics or capabilities, different case definitions, type of pertussis confirmation tests used, public awareness of the disease, as well as real differences in the magnitude of the disease, or a combination of these factors. Our study highlights the need to standardize pertussis detection and confirmation in surveillance programs across Europe, complemented with carefully-designed seroprevalence studies using the same protocols and methodologies.
27257822	12	25	Epidemiologic	T169	C0014508
27257822	26	41	Characteristics	T080	C1521970
27257822	45	54	Pertussis	T047	C0043167
27257822	61	68	Central	T083	C0454714
27257822	73	99	Eastern European Countries	T083	C0015177
27257822	127	149	epidemiological survey	T062	C0376688
27257822	157	163	annual	T079	C0332181
27257822	164	173	incidence	T081	C0021149
27257822	177	186	pertussis	T047	C0043167
27257822	187	195	reported	T058	C0700287
27257822	221	228	Central	T083	C0454714
27257822	233	259	Eastern European countries	T083	C0015177
27257822	291	300	pertussis	T047	C0043167
27257822	301	308	reports	T170	C0025102
27257822	317	326	countries	T083	C0454664
27257822	389	397	features	T080	C2348519
27257822	406	413	country	T083	C0454664
27257822	419	425	annual	T079	C0332181
27257822	426	435	incidence	T081	C0021149
27257822	439	448	pertussis	T047	C0043167
27257822	470	479	countries	T083	C0454664
27257822	507	530	government institutions	T093	C2607850
27257822	538	567	national surveillance systems	T093	C1708333
27257822	572	580	reviewed	T080	C1709940
27257822	585	592	changes	T169	C0392747
27257822	600	609	pertussis	T047	C0043167
27257822	610	625	incidence rates	T081	C1708485
27257822	634	641	country	T083	C0454664
27257822	653	664	differences	T080	C1705242
27257822	672	684	similarities	T080	C2348205
27257822	693	702	countries	T083	C0454664
27257822	718	727	pertussis	T047	C0043167
27257822	728	740	surveillance	T169	C0220920
27257822	742	758	case definitions	T170	C0679227
27257822	763	772	detection	T033	C0442726
27257822	777	789	confirmation	T080	C0521091
27257822	793	802	pertussis	T047	C0043167
27257822	804	813	incidence	T081	C0021149
27257822	818	833	number of cases	T081	C0021149
27257822	837	846	pertussis	T047	C0043167
27257822	850	854	year	T079	C0439234
27257822	871	880	age group	T100	C0027362
27257822	882	892	population	T098	C1257890
27257822	896	900	year	T079	C0439234
27257822	917	926	age group	T100	C0027362
27257822	928	937	pertussis	T047	C0043167
27257822	938	959	immunization schedule	T061	C0020972
27257822	964	972	coverage	T169	C1999244
27257822	990	1019	whole-cell pertussis vaccines	T121,T129	C0031237
27257822	1021	1023	wP	T121,T129	C0031237
27257822	1028	1056	acellular pertussis vaccines	T121,T129	C0982332
27257822	1058	1060	aP	T121,T129	C0982332
27257822	1073	1086	heterogeneity	T080	C0019409
27257822	1094	1102	reported	T058	C0700287
27257822	1103	1109	annual	T079	C0332181
27257822	1110	1125	incidence rates	T081	C1708485
27257822	1153	1162	countries	T083	C0454664
27257822	1164	1172	Reported	T058	C0700287
27257822	1173	1182	pertussis	T047	C0043167
27257822	1183	1198	incidence rates	T081	C1708485
27257822	1256	1266	population	T098	C1257890
27257822	1277	1284	highest	T080	C1522410
27257822	1285	1290	rates	T081	C1521828
27257822	1301	1309	reported	T058	C0700287
27257822	1313	1320	Estonia	T083	C0014908
27257822	1329	1335	lowest	T080	C1708760
27257822	1339	1346	Hungary	T083	C0020174
27257822	1351	1357	Serbia	T083	C0036708
27257822	1372	1378	burden	T078	C2828008
27257822	1408	1415	infants	T100	C0021270
27257822	1420	1424	year	T079	C0439234
27257822	1429	1437	Bulgaria	T083	C0006368
27257822	1439	1446	Hungary	T083	C0020174
27257822	1448	1454	Latvia	T083	C0023128
27257822	1456	1463	Romania	T083	C0035826
27257822	1469	1475	Serbia	T083	C0036708
27257822	1512	1521	countries	T083	C0454664
27257822	1532	1538	burden	T078	C2828008
27257822	1559	1573	older children	T100	C0008059
27257822	1582	1594	surveillance	T169	C0220920
27257822	1598	1604	adults	T100	C0001675
27257822	1659	1674	associated with	T080	C0332281
27257822	1691	1693	wP	T121,T129	C0031237
27257822	1697	1708	aP vaccines	T121,T129	C0982332
27257822	1712	1720	reported	T058	C0700287
27257822	1721	1730	pertussis	T047	C0043167
27257822	1731	1746	incidence rates	T081	C1708485
27257822	1752	1765	heterogeneity	T080	C0019409
27257822	1769	1777	reported	T058	C0700287
27257822	1778	1782	data	T078	C1511726
27257822	1813	1820	factors	T169	C1521761
27257822	1831	1843	surveillance	T169	C0220920
27257822	1844	1850	system	T169	C0449913
27257822	1851	1866	characteristics	T080	C1521970
27257822	1870	1882	capabilities	T080	C2698977
27257822	1894	1910	case definitions	T170	C0679227
27257822	1912	1916	type	T080	C0332307
27257822	1920	1929	pertussis	T047	C0043167
27257822	1930	1948	confirmation tests	T059	C0022885
27257822	1955	1961	public	T092	C0678367
27257822	1962	1971	awareness	T033	C1328734
27257822	1979	1986	disease	T047	C0043167
27257822	2004	2015	differences	T081	C1705241
27257822	2023	2032	magnitude	T081	C1704240
27257822	2040	2047	disease	T047	C0043167
27257822	2075	2082	factors	T169	C1521761
27257822	2129	2138	pertussis	T047	C0043167
27257822	2139	2148	detection	T033	C0442726
27257822	2153	2165	confirmation	T080	C0521091
27257822	2169	2190	surveillance programs	T062	C1515095
27257822	2198	2204	Europe	T083	C0015176
27257822	2243	2265	seroprevalence studies	T062	C0600367
27257822	2281	2290	protocols	T170	C0442711
27257822	2295	2308	methodologies	T062	C0086912